CITY OF HOPE and Wilshire Oncology Medical Group have reached an agreement in which Wilshire physicians will join City of Hope Medical Group in California, delivering care to patients through new community practice sites in Glendora, Pomona, Rancho Cucamonga, West Covina and Corona.
MARGARET FOTI, chief executive officer of the American Association for Cancer Research, received the Ellen V. Sigal Advocacy Leadership Award from Friends of Cancer Research at its Cancer Leadership Awards Reception in Washington, D.C.
THE LEUKEMIA AND LYMPHOMA SOCIETY and OncoPep entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma, an asymptomatic stage of myeloma. The partnership is through the society's Therapy Acceleration Program.
DENOVO BIOPHARMA acquired enzastaurin from Eli Lilly and Co. Denovo gains all rights to develop, manufacture and commercialize enzastaurin globally, including transfer of all intellectual property and other rights, data, and information.
DAVID TWEARDY was named division head of internal medicine of MD Anderson Cancer Center effective Dec. 1.
SUTRO BIOPHARMA and the biopharmaceutical division of Merck KGaA in Darmstadt, Germany, which operates as EMD Serono in the U.S. and Canada, announced a collaboration and license agreement to develop antibody drug conjugates.
SOLIGENIX INC. reached an agreement with FDA on the design of a phase III clinical trial evaluating SGX301 (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma.
BOEHRINGER INGELHEIM and CureVac announced an exclusive global license and development collaboration focused on CureVac's CV9202, a novel investigational therapeutic mRNA vaccine in early clinical development for the treatment of lung cancer.
MEMORIAL SLOAN KETTERING CANCER CENTER began construction on a 285,000-square-foot outpatient cancer treatment facility in Middletown, N.J., with plans to open in late 2016.
DAN GLICKMAN was named to the board of directors of the American Cancer Society Cancer Action Network.
